We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
355 hedge funds and large institutions have $1.91B invested in ADMA Biologics in 2026 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 135 increasing their positions, 109 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
129% more call options, than puts
Call options by funds: $67.1M | Put options by funds: $29.3M
24% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 109
15% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 61
0% less funds holding
Funds holding: 356 → 355 (-1)
3.69% less ownership
Funds ownership: 92.63% → 88.94% (-3.7%)
52% less capital invested
Capital invested by funds: $4.02B → $1.91B (-$2.11B)
75% less funds holding in top 10
Funds holding in top 10: 8 → 2 (-6)
Holders
355
Holders Change
-1
Holders Change %
-0.28%
% of All Funds
4.37%
Holding in Top 10
2
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
70
Increased
135
Reduced
109
Closed
61
Calls
$67.1M
Puts
$29.3M
Net Calls
+$37.9M
Net Calls Change
+$6.76M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$71.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$67.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$45.7M |
| 4 |
Millennium Management
New York
|
+$43.6M |
| 5 |
Jane Street
New York
|
+$40.9M |
